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Supplementary Figure 1 Gating strategy for the quantification of AnnexinV-positive cells in T4EM, 18 hours after irradiation at 2Gy of a PBMC sample.
Data was analyzed using FlowJo (v9.6.4).
Exclusion of doublets using a gate on FSC vs Pulse Width (panel a). Lymphocyte gating using a large scattergate, shaped to include apoptotic lymphocytes (lower FSC, higher SSC; panel b). Exclusion of dead cells on the basis of HO33258 fluorescence (panel c). T lymphocytes were identified on the basis of positive PETxR (CD3) fluorescence (panel d).
Identification of T4-and T8 lymphocytes through PECy7 (CD4) vs APCH7 (CD8) fluorescence (panel e). APC (CD45RA) vs PE (CD62L) histograms to identify naïve (N; CD62L+CD45RA+), central memory (CM; CD62L+CD45RA-), effector memory (EM; CD62L-CD45RA-), and terminal effector (TE; CD62L-CD45RA+) T4 and T8 (panel f). The proportion of apoptotic cells was finally determined by application of an identical gate on a bivariate FSC vs FITC (AnV) to all of the identified subpopulations (exemplified for T4EM; panel i).
Dot plots show absence of AnnexinV positive cells in T8-and T4 CD62L expressing lymphocytes (panels g and h, respectively). Higher expression of surface bound TRAIL (mTRAIL; CD253) in a sensitive sample (red contours) as compared to a resistant sample (blue contours).
T4EM lymphocytes were gated according to the strategy outlined in Supplementary Figure 1 . Overlayed NbyN representation of contour plots of T4EM lymphocytes for FSC, AnnexinV, CD253 (TRAIL), and CD262 (DR5), illustrating increased expression of mTRAIL in sensitive samples.
